Evidence map›Paper›PMID 31197154›Full record

ArticleNature communications2019

COMPASS for rapid combinatorial optimization of biochemical pathways based on artificial transcription factors.

Gita Naseri, Jessica Behrend, Lisa Rieper, Bernd Mueller-Roeber

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Quantitative and modularized CRISPR/dCas9-dCpf1 dual function system inFrontiers in bioengineering and biotechnology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Saccharomyces cerevisiae as a Heterologous Host for Natural Products.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Gita NaseriUniversity of Potsdam, Cell2Fab Research Unit, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany.ORCID http://orcid.org/0000-0002-4630-3141
Jessica BehrendUniversity of Potsdam, Cell2Fab Research Unit, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany.
Lisa RieperUniversity of Potsdam, Cell2Fab Research Unit, Karl-Liebknecht-Str. 24-25, 14476, Potsdam, Germany.
Bernd Mueller-RoeberUniversity of Potsdam, Department Molecular Biology, Karl-Liebknecht-Str. 24-25, House 20, 14476, Potsdam, Germany. bmr@uni-potsdam.de.ORCID http://orcid.org/0000-0002-1410-464X
University of Potsdam · DE

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 031A172Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 031B0223
6 · The paper itself

Abstract

Balanced expression of multiple genes is central for establishing new biosynthetic pathways or multiprotein cellular complexes. Methods for efficient combinatorial assembly of regulatory sequences (promoters) and protein coding sequences are therefore highly wanted. Here, we report a high-throughput cloning method, called COMPASS for COMbinatorial Pathway ASSembly, for the balanced expression of multiple genes in Saccharomyces cerevisiae. COMPASS employs orthogonal, plant-derived artificial transcription factors (ATFs) and homologous recombination-based cloning for the generation of thousands of individual DNA constructs in parallel. The method relies on a positive selection of correctly assembled pathway variants from both, in vivo and in vitro cloning procedures. To decrease the turnaround time in genomic engineering, COMPASS is equipped with multi-locus CRISPR/Cas9-mediated modification capacity. We demonstrate the application of COMPASS by generating cell libraries producing β-carotene and co-producing β-ionone and biosensor-responsive naringenin. COMPASS will have many applications in synthetic biology projects that require gene expression balancing.

Indexed as

Arabidopsis Proteinsbeta CaroteneBiosensing TechniquesBiosynthetic PathwaysCloning, MolecularCRISPR-Cas SystemsFlavanonesHomologous RecombinationMetabolic EngineeringNorisoprenoidsPromoter Regions, GeneticSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSynthetic BiologyTranscription FactorsArabidopsis Proteinsbeta Carotenebeta-iononeFlavanonesnaringeninNorisoprenoidsSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID31197154
PMCPMC6565718
OpenAlexW2950767474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.